26.00
Updated 15/11/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 598,577
High 26.01
Low 25.71
Open 25.88
ISIN ES0171996087
Prev close 26.00
# of shares -
Market cap -
Intraday

Market closed
Grifols S.A.
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  26.00 0.0% Stock price decreasing 12.2% Stock price increasing 5.9% Stock price increasing 3.3% Stock price increasing 3.2% Stock price increasing
Powered by TradingView

Company profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 November 2018 20:23:07
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181114.1 - EUROWEB1 - 2018-11-19 21:23:07 - 2018-11-19 20:23:07 - 1000 - Website: OKAY